On September 8, 2026, NGT’s Mark A. Krook, PhD, CMC & Early Drug Development, will join experts from Quotient Sciences for a live webinar on one of the most persistent challenges in drug development: how to build a formulation strategy for poorly soluble molecules that remains viable as the program moves forward.

During this one-hour session, the speakers will explore how early formulation choices can influence what comes next, from manufacturing and scale-up to technology transfer and clinical development. The discussion will include key solubility-enhancement approaches such as hot melt extrusion, spray-dried dispersions, lipid-based formulations and particle size reduction with a focus on selecting the right strategy for the molecule and the wider development path.

The webinar will also examine how stronger alignment between formulation, manufacturing and clinical planning can help reduce downstream risk and support faster, better-informed development decisions.

Tuesday, September 8, 2026
10am EDT | 3pm BST | 4pm CEST
Online live webinar

Register free HERE